CELLUPRO LTD

Overview

CELLUPRO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CELLIMAX CHO E MEDIUM; CELLIMAX CHO FGA MEDIUM; CELLMAX CHO FGB MEDIUM; F109 MEDIUM; MAXP CHO F100 MEDIUM; SFM001 MEDIUM.

API / Drug Master Files

CELLUPRO LTD holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CELLIMAX CHO FGA MEDIUMActive2025-06-17
• CELLMAX CHO FGB MEDIUMActive2025-05-22
• CELLIMAX CHO E MEDIUMActive2025-05-22
• F109 MEDIUMActive2024-12-16
• SFM001 MEDIUMActive2024-10-11
• SFM002 MEDIUMActive2023-06-26
• MAXP CHO F100 MEDIUMActive2023-06-26

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CELLUPRO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.